Skip to main content
Premium Trial:

Request an Annual Quote

Raynard Kington, Elias Zerhouni, Jonathan Sheridan, John Elling

Raynard Kington became the acting director of the National Institutes of Health, following the departure of Elias Zerhouni, as of Oct. 31. Kington has taken over the post until President-elect Barack Obama appoints a new director. He has served as Zerhouni’s deputy since 2003. Prior to that, he was associate director of NIH for behavioral and social sciences research.

Jonathan Sheridan is the new president and CEO at Integrated Genomics, a bioinformatics products and services provider that specializes in microbial genomics. He takes over from John Elling who will remain chairman of the board.
Prior to Integrated Genomics, Sheridan was VP of commercial operations at HTG, where he was responsible for forming new business partnerships with pharmaceutical and life sciences companies, establishing research agreements with academic institutions, and managing the global commercial sales and marketing teams.
Sheridan also held senior positions with PerkinElmer Life and Analytical Sciences, Epicentre Biotechnologies, Genomica, Lion Biosciences, PerkinElmer Cetus, Beckman Coulter, and Monsanto.

Filed under

The Scan

Billions for Antivirals

The US is putting $3.2 billion toward a program to develop antivirals to treat COVID-19 in its early stages, the Wall Street Journal reports.

NFT of the Web

Tim Berners-Lee, who developed the World Wide Web, is auctioning its original source code as a non-fungible token, Reuters reports.

23andMe on the Nasdaq

23andMe's shares rose more than 20 percent following its merger with a special purpose acquisition company, as GenomeWeb has reported.

Science Papers Present GWAS of Brain Structure, System for Controlled Gene Transfer

In Science this week: genome-wide association study ties variants to white matter stricture in the brain, and more.